Citigroup’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Sell |
22,913
-8,201
| -26% | -$37K | ﹤0.01% | 3661 |
|
|
2025
Q1 | $144K | Sell |
31,114
-13,769
| -31% | -$63.9K | ﹤0.01% | 3618 |
|
|
2024
Q4 | $311K | Buy |
44,883
+14,780
| +49% | +$103K | ﹤0.01% | 3311 |
|
|
2024
Q3 | $160K | Buy |
30,103
+20,565
| +216% | +$109K | ﹤0.01% | 3736 |
|
|
2024
Q2 | $35.7K | Buy |
9,538
+3,640
| +62% | +$13.6K | ﹤0.01% | 4043 |
|
|
2024
Q1 | $41.6K | Buy |
5,898
+1,500
| +34% | +$10.6K | ﹤0.01% | 3969 |
|
|
2023
Q4 | $24.8K | Buy |
4,398
+3,691
| +522% | +$20.9K | ﹤0.01% | 4146 |
|
|
2023
Q3 | $3.39K | Sell |
707
-10,271
| -94% | -$49.2K | ﹤0.01% | 4080 |
|
|
2023
Q2 | $75.2K | Buy |
10,978
+9,939
| +957% | +$68.1K | ﹤0.01% | 3708 |
|
|
2023
Q1 | $8.09K | Sell |
1,039
-301
| -22% | -$2.35K | ﹤0.01% | 4149 |
|
|
2022
Q4 | $10.2K | Sell |
1,340
-170
| -11% | -$1.29K | ﹤0.01% | 4126 |
|
|
2022
Q3 | $12K | Sell |
1,510
-1,675
| -53% | -$13.3K | ﹤0.01% | 4192 |
|
|
2022
Q2 | $31K | Buy |
3,185
+690
| +28% | +$6.72K | ﹤0.01% | 4085 |
|
|
2022
Q1 | $35K | Sell |
2,495
-2,308
| -48% | -$32.4K | ﹤0.01% | 4177 |
|
|
2021
Q4 | $98K | Buy |
4,803
+3,482
| +264% | +$71K | ﹤0.01% | 3981 |
|
|
2021
Q3 | $29K | Buy |
+1,321
| New | +$29K | ﹤0.01% | 4298 |
|